Moderna, Merck Stock Jumps on Melanoma Vaccine News -- WSJ
Dow Jones2026/08/19 11:17By WSJ Staff
An experimental mRNA-based vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients, Moderna and its partner Merck said.
Shares in Moderna jumped about 10% premarket, while Merck also climbed around 6%.
The success paves the way for a potentially new life-extending treatment for the thousands of people diagnosed with the deadly skin cancer each year.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
August 19, 2026 07:17 ET (11:17 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US stock index adjustments to take effect next Monday: Bloom Energy (BE.US) and Everpure (P.US) to be included in S&P 500, changes also for mid- and small-cap stocks
Bloom Energy, Illumina, and Everpure will be included in the S&P 500 index, while several other companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
Is the Federal Reserve repeating the 2022-style rate hikes? Bank of America warns: Rates may return above 5%, suggests shorting two-year U.S. Treasuries.
Bank of America warns: With Waller at the helm, the Federal Reserve may raise interest rates above 5%, potentially repeating the events of 2022.
OpenAI is expected to burn over $278 billion in cash by 2030, with a revenue target of $350 billion over the same period.
OpenAI is expected to generate up to $278 billion in negative free cash flow over the next five years, driven solely by computing power and infrastructure, with cumulative spending projected to reach approximately $856 billion by 2030. The company anticipates revenue of $350 billion in 2030 and $36 billion in 2026, with total revenue from 2026 to 2030 amounting to around $840 billion.